Su-ning Chen
The First Affiliated Hospital of Soochow University · (0086)13814881746
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Su-ning Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:30 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07559695 · A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCTThe First Affiliated Hospital of Soochow University · recruiting · Menin Inhibitors, Acute Leukemia, Post Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2NCT07101497 · Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute LeukemiaThe First Affiliated Hospital of Soochow University · recruiting · Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation, Maintenance Therapy · principal investigator
- Ph2/Ph3NCT05939180 · VA vs DA for Newly Diagnosed Hig-risk AMLThe First Affiliated Hospital of Soochow University · recruiting · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in acute myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 10:30 UTC. The ranking covers the 200 most relevant of 34 PubMed records, and a shared surname and initials can bring in a namesake. All 34 on PubMed
- 1,185 citationsRCR 26.9
- All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.Proc Natl Acad Sci U S A · 2004487 citationsRCR 9.3
- 471 citationsRCR 10.1
- Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report.Blood · 2002166 citationsRCR 3.6
- 156 citationsRCR 4.5
- Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.Lancet Oncol · 2013148 citationsRCR 3.9
- Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China.Proc Natl Acad Sci U S A · 2013120 citationsRCR 3.0
- Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.Haematologica · 201171 citationsRCR 1.4
- Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.Leukemia · 199663 citationsRCR 1.5
- Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim.Br J Haematol · 201159 citationsRCR 1.4